Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
about
Current and potential pharmacological treatments for obsessive-compulsive disorderObsessive-compulsive disorder and trichotillomania: a phenomenological comparisonA comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant actionHow the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacologyOn the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?Sertraline in the treatment of anxiety disorders.Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.Management of anxiety disorders: the added challenge of comorbidity.Psychopharmacology of anxiety disorders.Obsessive compulsive neurosis : clomipramine, prolactin and therapeutic response.Pharmacotherapy of anxious disorders.Obsessive-compulsive disorder: a critical review of therapeutic perspectives.Clinical pharmacology and therapeutics.An update on the pharmacological treatment of obsessive-compulsive disorder.Integrating precision medicine in the study and clinical treatment of a severely mentally ill personPharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder.Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines.Contemporary approaches to pharmacotherapy in Tourette's syndrome and obsessive-compulsive disorder.Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation.Treatment of obsessive compulsive disorder: Algorithms for pharmacotherapy.Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.Serotonergic compounds in panic disorder, obsessive-compulsive disorder and anxious depression: A concise review.
P2860
Q22306025-474887F2-7E34-4BAD-BB6A-D3671B7D6537Q24793138-3DFFD05F-D2AE-42B0-87FD-049058DEDBC8Q28316018-5E4F9773-B665-445F-BA0E-D083824C9F37Q30485725-6FE25525-B1A9-441F-A413-4ABC5813D817Q33538059-8A6E6A24-917D-4703-B236-39D9CA421165Q33898364-9F25A26F-3B41-4888-A54E-96A44116945DQ33914087-4716B09F-EB9E-410F-AC46-9A7374F66DC6Q34108465-66543BF4-CF0E-4D40-AB69-3542C2920402Q34218830-D72FFDF3-7ABE-4775-881F-C8BCE982FFECQ34228150-A52441C7-F2DF-448F-85A6-47A49E4CF481Q34256200-84A244FA-56AE-4877-BA51-4B0C2593B9FCQ35011794-E3584141-0931-484B-A26B-743767D5C58BQ36058933-A6948D1C-403D-4ADA-AD1C-6CFE8D98D37DQ36682367-A5367843-9882-432E-835D-B98F2892D3A9Q36765772-138B84A0-C77D-42D3-96BE-A3A941BFB3C4Q37219339-797D17D6-73E8-4E4D-A21B-38F070BD9374Q38057736-979E9889-9F06-4DF3-8411-AEC7570A07D2Q38092129-BE826B9B-783E-44CD-893B-A13E4555E6E5Q38207094-B4F63DDB-6745-48E2-B919-50A6F787AC3AQ38573611-ACD2ACAD-E80D-4A2F-9CB2-F1A778EA7E39Q39274236-3C8171E8-7944-44D4-A68F-9BD36C6671CFQ41025805-4079286F-2B24-4FCC-9A2B-E5BA213B79AFQ43740421-72AD2CA7-4B9E-4403-9AB9-4F1BE624DD56Q48019154-74BB656C-5A81-4A34-948C-FF047AD3F8FCQ48178959-6127AEBE-7C5C-46E7-AB08-53938022B231Q52278376-47C6684F-4CB1-4363-A688-A5D807121F45Q53962416-B3931716-B3D7-4458-B073-2A31BA24470DQ54001527-82B0215D-5FAC-4786-A274-074CC6D77D85
P2860
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Controlled comparisons of clom ...... vioral and biological results.
@en
Controlled comparisons of clom ...... vioral and biological results.
@nl
type
label
Controlled comparisons of clom ...... vioral and biological results.
@en
Controlled comparisons of clom ...... vioral and biological results.
@nl
prefLabel
Controlled comparisons of clom ...... vioral and biological results.
@en
Controlled comparisons of clom ...... vioral and biological results.
@nl
P2093
P1433
P1476
Controlled comparisons of clom ...... vioral and biological results.
@en
P2093
Bernstein SE
Tolliver TJ
P304
P356
10.1001/ARCHPSYC.1990.01810220042005
P407
P577
1990-10-01T00:00:00Z